Korean J Crit Care Med.
2011 Jun;26(2):117-121. 10.4266/kjccm.2011.26.2.117.
Amiodarone-induced Pulmonary Toxicity within a Short Period of the Initiation of Amiodarone Therapy: A Case Report
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, Hanil General Hospital, Seoul, Korea. jimmy5058@hanmail.net
- 2Division of Pulmonology, Department of Internal Medicine, Hanil General Hospital, Seoul, Korea.
- KMID: 1977498
- DOI: http://doi.org/10.4266/kjccm.2011.26.2.117
Abstract
- Amiodarone is one of the most commonly prescribed antiarrhythmic drug for almost all atrial or ventricular arrythmias. Amiodarone-induced pulmonary toxicity (APT) was first described in 1980 and has potentially serious side effects that are believed to develop in 5% of patients. In general, APT occurs only when high amiodarone doses are used for a long time. However, during short-term therapy of amiodarone, APT is rarely reported. In this report, we describe a case of amiodarone-induced pulmonary toxicity after a short course of amiodarone therapy for atrial fibrillation.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Amiodarone-Induced Pulmonary Toxicity
- A Case of Amiodarone-Induced Pulmonary Toxicity After a Long Course of a Low Dose Therapy
- Amiodarone-Induced Pulmonary Toxicity: Percutaneous Needle Aspiration Biopsy and Ultrastructural Findings
- Very Early Onset of Amiodarone-Induced Pulmonary Toxicity
- Amiodarone Induced Keratopathy
